Home
Conditions
Pancreatic Cancer

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 285 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Not Yet Recruiting

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

NCT06346808

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer

NCT06259058

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer

NCT06233877

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Hirscheld Oncology Brooklyn, New York, United States

View Trial Details

Not Yet Recruiting

Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients

NCT06234072

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Shenzhen University General Hospital Shenzhen, Guangdong, China

View Trial Details

Not Yet Recruiting

HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

NCT06217042

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX

NCT06210360

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer

NCT06196658

Conditions: Advanced Biliary Cancer, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

NCT06156267

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer

NCT05810792

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor

NCT06134960

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Pancreatic Cancer

Pancreatic Cancer trial results

Related conditions